Skip to content
Article about TruScreen using the R&D Tax incentive for working capital

Turn Research and Development expenditure into working capital

Australasian BioTechnology, the official journal of AusBiotech, featured an article covering TCF Services’ unique prepayment solution, which allows R&D Tax Incentive claimants turn their claim into working capital.

R&D Capital Partners is proud to offer eligible R&D companies a unique competitive advantage through their R&D Tax prepayment service. Under this initiative, companies eligible for the 43.5% refundable tax offset with annual aggregated R&D turnover less than $20 million may receive a prepayment of up to 80% against their R&D Tax Incentive benefit prior to lodging their ATO tax return.

Two distinct prepayment offerings are available based upon meeting R&D Capitals’ due diligence requirements. The first offering allows eligible R&D companies to receive a prepayment against their prior year’s expenses before registering their annual activities and lodging the company’s tax return. The second prepayment offering allows eligible R&D companies to draw down up to 80% of its benefit against current year R&D expenditure on a quarterly or half-yearly basis.

This initiative enables R&D start-ups access to additional working capital when they need it most to support their R&D and commercialisation strategies. If you have any questions or are interested in participating please call David Tonkin or Gerry Frittmann on (02) 8219 4900 or visit rdcapital.net.au for more information

Click below to the read the article detailing how our prepay is assisting biotech companies in Australia.